138 related articles for article (PubMed ID: 15539924)
1. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.
Santodirocco M; Lombardi V; Fesce C; Palumbo G; Capalbo S; Landriscina M
Acta Oncol; 2008; 47(8):1602-4. PubMed ID: 18607839
[No Abstract] [Full Text] [Related]
3. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-induced immune pancytopenia.
Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
Tonini G; Santini D; Vincenzi B; Borzomati D; Dicuonzo G; La Cesa A; Onori N; Coppola R
J Biol Regul Homeost Agents; 2002; 16(2):105-9. PubMed ID: 12144121
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
[TBL] [Abstract][Full Text] [Related]
8. Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.
Pietrantonio F; Di Bartolomeo M; Buzzoni R; Bajetta E
Tumori; 2010; 96(1):154-6. PubMed ID: 20437874
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
[TBL] [Abstract][Full Text] [Related]
10. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
Shao YY; Hong RL
Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
[TBL] [Abstract][Full Text] [Related]
14. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Sørbye H; Bruserud Y; Dahl O
Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
[No Abstract] [Full Text] [Related]
17. Oxaliplatin-induced acute thrombocytopenia.
Mason JM; Rees GJ
J Oncol Pharm Pract; 2011 Dec; 17(4):433-5. PubMed ID: 20699331
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
19. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
20. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.
Lai JI; Wang WS
Pharm World Sci; 2009 Oct; 31(5):538-541. PubMed ID: 19588266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
